Canada cannot rest on past success in the field of biotechnology, according to a report released today by The Conference Board of Canada.

Canada’s modest investments in biotechnology are spread across a range of industry sectors.

“Other leading countries are making more strategic decisions about their investments to achieve international competitive advantages,” said Trefor Munn- Venn, author of the report, Biotechnology in Canada: A Technology Platform for Growth. “To achieve international success in biotechnology, we must develop critical mass in our research investments, in our talent pool and in our biotechnology companies.”

The Conference Board report raises policy questions for industry, the academic community and government.